Facing the evidence: antidepressant treatment in children and adolescents
- PMID: 14970097
- PMCID: PMC332716
Facing the evidence: antidepressant treatment in children and adolescents
Comment in
-
Antidepressants and adverse effects in young patients: uncovering the evidence.CMAJ. 2004 Feb 17;170(4):487-9. CMAJ. 2004. PMID: 14970096 Free PMC article. No abstract available.
-
SSRI treatment for under-18s.CMAJ. 2004 Jun 8;170(12):1771; author reply 1171-2. doi: 10.1503/cmaj.1040396. CMAJ. 2004. PMID: 15184311 Free PMC article. No abstract available.
References
-
- Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE. Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 1996;35(12):1575-83. - PubMed
-
- American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998;37(10 Suppl):63S-83S. - PubMed
-
- Zito JM, Safer DJ, dosReis S, Gardner JF, Soeken K, Boles M, et al. Rising prevalence of antidepressants among US youths. Pediatrics 2002; 109(5):721-7. - PubMed
-
- Important Drug Safety Information Regarding Paxil in Pediatric Patients. GlaxoSmith Kline: Therapeutic Products Directorate. 2003 Jul. In: [Web site of Health Canada]. Available: www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/paxil_e.html (accessed 2004 Jan 22).
-
- Letter to physicians. Wyeth Pharmaceuticals. 22 Aug 2003. Available: www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/effexor_dhcpl_us_e.html (accessed 2004 Jan 22).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical